NEW YORK (GenomeWeb) – Hologic reported after the close of the market Wednesday that revenues for its fiscal first quarter were up about 7 percent year over year driven in part by growth in its diagnostics and molecular diagnostics businesses. 

The Bedford, Massachusetts-based firm reported total revenues of $695.2 million for the quarter ended Dec. 26, up from $652.8 million in the prior year and above the Wall Street estimate of $688 million. On a constant currency basis, Q1 revenues grew 8 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.